.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 9,138,415

« Back to Dashboard

Details for Patent: 9,138,415

Title:Stable pharmaceutical composition and methods of using same
Abstract: The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.
Inventor(s): Manku; Mehar (Birmingham, GB), Osterloh; Ian (Kent, GB), Wicker; Pierre (Mystic, CT), Braeckman; Rene (Richboro, PA), Soni; Paresh (Mystic, CT)
Assignee: Amarin Pharmaceuticals Ireland Limited (Dubin, IE)
Filing Date:Sep 18, 2013
Application Number:14/030,900
Claims:1. A pharmaceutical composition, comprising: omega-3 fatty acids in free acid form including (a) eicosapentaenoic acid in an amount selected from about 1000 mg, about 1650 mg and about 2200 mg; (b) docosahexaenoic acid in an amount of about 20%, by weight of total fatty acids; and docosapentaenoic acid in an amount of about 5%, by weight of total fatty acids.

2. The pharmaceutical composition of claim 1 wherein the eicosapentaenoic acid is present in an amount of about 1000 mg.

3. The pharmaceutical composition of claim 1 wherein the eicosapentaenoic acid is present in an amount of about 1650 mg.

4. The pharmaceutical composition of claim 1 wherein the eicosapentaenoic acid is present in an amount of about 2200 mg.

5. The composition of claim 3 wherein the composition is present in one or more dosage units.

6. The composition of claim 5 wherein the dosage units comprise capsules.

7. A method of reducing triglycerides in a subject in need thereof comprising, administering to the subject daily a composition of claim 6.

8. The method of claim 7 wherein the subject has very high serum triglycerides and is at risk of pancreatitis.

9. A pharmaceutical composition comprising omega-3 fatty acids including: (a) about 1100 mg to about 1200 mg of eicosapentaenoic acid; (b) docosahexaenoic acid, and (c) docosapentaenoic acid, wherein the docosahexaenoic acid comprises not more than about 20% by weight of fatty acids in the composition and the docosapentaenoic acid comprises not more than about 7% by weight of fatty acids present in the composition.

10. The composition of claim 9 wherein the composition is present in one or more dosage units.

11. The composition of claim 10 wherein the dosage units comprise capsules.

12. A pharmaceutical composition comprising omega-3 fatty acids including: (a) about 1700 mg to about 1800 mg of eicosapentaenoic acid; (b) docosahexaenoic acid, and (c) docosapentaenoic acid, wherein the docosahexaenoic acid comprises not more than about 20% by weight of fatty acids in the composition and the docosapentaenoic acid comprises not more than about 7% by weight of fatty acids in the composition.

13. The composition of claim 12 wherein the composition is present in one or more dosage units.

14. The composition of claim 13 wherein the dosage units comprise capsules.

15. A pharmaceutical composition comprising omega-3 fatty acids including: (a) about 2200 mg to about 2300 mg of eicosapentaenoic acid; (b) docosahexaenoic acid, and (c) docosapentaenoic acid, wherein the docosahexaenoic acid comprises not more than about 20% by weight of fatty acids in the composition and the docosapentaenoic acid comprises not more than about 7% by weight of fatty acids in the composition.

16. The composition of claim 15 wherein the composition is present in one or more dosage units.

17. The composition of claim 16 wherein the dosage units comprise capsules.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc